Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;33(7):576-586.
doi: 10.5152/tjg.2022.21780.

Prevalence and Determinants of Gastrointestinal Manifestations in Patients with Selected Rheumatologic Diseases

Emra Asfuroğlu Kalkan  1 , Çağdaş Kalkan  2 , Sezgin Barutcu  3 , Orhan Küçükşahin  4 , Özge Güçbey  1 , Tankut Köseoğlu  2 , Ateş Şendil  5 , Mevlüt Hamamcı  2 , Ersan Özaslan  2 , İhsan Ateş  1 , Emin Altıparmak  2 , İrfan Soykan  6
Affiliations

Prevalence and Determinants of Gastrointestinal Manifestations in Patients with Selected Rheumatologic Diseases

Emra Asfuroğlu Kalkan et al. Turk J Gastroenterol. 2022 Jul.

Abstract

Background: Many rheumatic diseases may cause gastrointestinal manifestations. The goal of this study was to analyze the prevalence and predictors of gastrointestinal involvement in patients with rheumatic disorders.

Methods: A retrospective chart review was performed for patients with systemic lupus erythematosus, rheumatoid arthritis, and sys- temic sclerosis who have consulted due to gastrointestinal symptoms. The relationship between clinical symptoms, gastroscopic/colo- noscopic findings, and histopathological results with current drugs and disease duration was evaluated.

Results: A total of 364 patients with rheumatic disorders and 740 people as control group were included in the study. Abdominal bloating followed by abdominal pain, regurgitation, and heartburn were reported as the main complaints by more than half of the patients. Most of the patients had gastric mucosal changes expressed as Lanza score, and the presence of major polypharmacy was the most important factor affecting Lanza score (odds ratio: 10, 95% CI: 1.882-54.111, P < .007) followed by disease duration (odds ratio: 1.559, 95% CI: 1.369-1.775, P < .001) and age (odds ratio: 1.069, 95% CI: 1.030-1.109, P < .001). In general, approximately 30% of the patients were posi- tive for Helicobacter pylori infection and 35% showed intestinal metaplasia in histopathological examination. Most of the colonoscopic findings were associated with colonic polyps (n = 81). In multivariate analysis, disease duration was the only factor that affected the pres- ence of colonic lesions (Area Under the Receiver Operating Characteristic (ROC) Curve (AUROC): 0.871, 95% CI: 0.824-0.918, P < .001).

Conclusion: Patients with rheumatologic diseases frequently have gastrointestinal manifestations. The most encountered gastrointes- tinal symptom was abdominal bloating, followed by abdominal pain. Being aware of gastrointestinal manifestations and their determi- nants may help physicians manage and follow patients with rheumatologic disorders.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Receiver operating curves for disease duration as a predictor of (1) intestinal metaplasia, (2) gastric atrophy, (3) gastroscopic Lanza score, and (4) colonoscopic findings.
See this image and copyright information in PMC

References

    1. Youssef WI, Tavill AS. Connective tissue diseases and the liver. J Clin Gastroenterol. 2002;35(4):345 349. 10.1097/00004836-200210000-00012) - DOI - PubMed
    1. Sallam H, McNearney TA, Chen JD. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther. 2006;23(6):691 712. 10.1111/j.1365-2036.2006.02804.x) - DOI - PubMed
    1. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37(4):223 235. 10.1016/j.semarthrit.2007.05.003) - DOI - PubMed
    1. Li Z, Xu D, Wang Z, et al. Gastrointestinal system involvement in systemic lupus erythematosus. Lupus. 2017;26(11):1127 1138. 10.1177/0961203317707825). - DOI - PubMed
    1. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677 2686. 10.1002/art.34473) - DOI - PMC - PubMed

MeSH terms